MORRISON JODIE POPE (Interim CEO) reported 1 transaction at KERYX BIOPHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/13/2018ACC: 0000899243-18-030889
DirectorOfficer· Interim CEO
Since Jun 2018
-230K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
230K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−120K
Price / share
—
Trade value
—
% of position
New position
12/12/2018
120K→0.00
Total
Net shares
−120K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2018 | D · Disposition | −120K | — | — | New position | 120K | 0.00 |
| Total | −120K | $0.00 | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
110K shares
Shares
−110K
Strike price
Held after
0.00
Exercisable
—
12/12/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock110K shares | 12/12/2018 | D · Disposition | −110K | — | 0.00 |